OncoSec Medical Incorporated Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Narrative)

Stockholders' Equity (Details Narrative) - USD ($)								6 Months Ended
Stockholders' Equity (Details Narrative) - USD ($)	Dec. 06, 2018	Nov. 02, 2018	Oct. 08, 2018	Aug. 31, 2018	Nov. 13, 2017	Oct. 25, 2017	Jul. 25, 2017	Jan. 31, 2019	Jan. 31, 2018
Number of common stock shares issued related to option exercises								430,293
Proceeds from stock option exercise								$ 566,135	$ 157,928
Number of warrant to purchase shares of common stock								8,928,905
Net proceeds from cash exercise of warrants									9,593,733
Gross proceeds from offering								14,141,895	7,886,913
Net proceeds from issuance of public offering								$ 23,390	$ 19,048
Warrant expire term, description								These warrants expire at various dates between May 2019 and April 2023.
Maximum [Member]
Warrant exercise price per share								$ 18.00
Minimum [Member]
Warrant exercise price per share								$ 1.25
Alpha Holdings, Inc. [Member]
Purchase price per share	$ 1.50		$ 1.50
Gross proceeds from common stock	$ 7,000,000		$ 8,000,000
Number of common stock shares issued	4,666,667		5,333,333
First October 2017 Offering [Member]
Fair value of warrants						$ 2,400,000
Dividend rate						0.00%
Expected term of volatility						5 years 6 months
Volatility rate						75.55%
Risk-free interest rate						2.12%
First October 2017 Offering [Member] \| Placement Agent [Member]
Number of warrant to purchase shares of common stock						316,256
Warrant exercise price per share						$ 1.68
Net proceeds from cash exercise of warrants						$ 6,200,000
Fair value of warrants						$ 200,000
Dividend rate						0.00%
Expected term of volatility						5 years
Volatility rate						73.25%
Risk-free interest rate						2.06%
Warrant expiry date						Oct. 21, 2022
Gross proceeds from offering						$ 7,100,000
Percentage of cash fee equal to gross proceeds of offering						5.50%
Offering expenses						$ 60,000
Second October 2017 Offering [Member] \| Placement Agent [Member]
Number of warrant to purchase shares of common stock						48,000
Warrant exercise price per share						$ 1.68
Net proceeds from cash exercise of warrants						$ 1,000,000
Fair value of warrants						$ 31,000
Dividend rate						0.00%
Expected term of volatility						5 years
Volatility rate						73.22%
Risk-free interest rate						2.06%
Warrant expiry date						Oct. 25, 2022
Gross proceeds from offering						$ 1,100,000
Percentage of cash fee equal to gross proceeds of offering						5.50%
Offering expenses						$ 15,000
Second October 2017 Offering [Member]
Fair value of warrants						$ 400,000
Dividend rate						0.00%
Expected term of volatility						5 years 6 months
Volatility rate						75.51%
Risk-free interest rate						2.12%
Accredited Investors [Member] \| First October 2017 Offering [Member]
Number of common stock shares sold under offering						5,270,934
Warrant exercise price per share						$ 1.25
Warrant exercisable date						Oct. 25, 2017
Purchase price per share						$ 1.34375
Warrant expiry date						Apr. 25, 2022
Accredited Investors [Member] \| First October 2017 Offering [Member] \| Maximum [Member]
Number of warrant to purchase shares of common stock						3,953,200
Accredited Investors [Member] \| Second October 2017 Offering [Member]
Number of common stock shares sold under offering						800,000
Warrant exercise price per share						$ 1.25
Warrant exercisable date						Apr. 27, 2018
Purchase price per share						$ 1.34375
Warrant expiry date						Apr. 27, 2022
Accredited Investors [Member] \| Second October 2017 Offering [Member] \| Maximum [Member]
Number of warrant to purchase shares of common stock						600,000
Stock Purchase Agreement [Member] \| Alpha Holdings, Inc. [Member]
Purchase price per share				$ 1.50
Stock Purchase Agreement [Member] \| Alpha Holdings, Inc. [Member] \| Maximum [Member]
Number of common stock shares sold, value				$ 15,000,000
Controlled Equity Offering Sales Agreement [Member]
Number of common stock shares sold, value		$ 30,000,000
Warrant Exercise Agreement [Member]
Number of warrant to purchase shares of common stock					5,509,642
Warrant exercise price per share					$ 1.69
Gross proceeds from exercise of warrants					$ 9,300,000
Estimated expenses paid or payable					9,100,000
Warrant Exercise Agreement [Member] \| Accredited Investors [Member]
Fair value of warrants					$ 2,500,000
Dividend rate					0.00%
Expected term of volatility					2 years
Volatility rate					73.12%
Risk-free interest rate					1.70%
Warrant Exercise Agreement [Member] \| Accredited Investors [Member] \| Maximum [Member]
Number of warrant to purchase shares of common stock					1,138,300
Warrant Exercise Agreement [Member] \| New Warrants [Member]
Number of warrant to purchase shares of common stock					1,377,411
Warrant exercise price per share					$ 2.26
Percentage of warrant to purchase common stock equal to common stock received					25.00%
Warrant exercisable date					May 13, 2018
Equity Distribution Agreement [Member] \| Oppenheimer & Co. Inc [Member]
Number of common stock shares sold under offering									897,311
Net proceeds from issuance of public offering							$ 1,100,000
Equity Distribution Agreement [Member] \| Oppenheimer & Co. Inc [Member] \| Maximum [Member]
Gross proceeds from offering							$ 8,400,000